Record mula sa primary source
Decision-gradePag-apruba ng FDA
Regeneron Pharmaceuticals Inc · Pinahintulutan ng FDA ang Pasatru (garetosmab-grts)
FDA's Purple Book lists BLA 761508 (Pasatru, garetosmab-grts; Regeneron Pharmaceuticals, Inc., CDER) as licensed on 2026-08-19.
Mahahalagang fact
- Na-file
- Ago 19, 2026, 12:00 AM
- Kaganapan
- Pag-apruba ng FDA
- Direksyon
- Positibo
- Kumpiyansa
- May source
REGNRegeneron